alphaXRT jobs and careers
As of October 24, 2026, alphaXRT has no open roles listed.
About alphaXRT
alphaXRT [formerly CMS alphatech] was founded in 1990 and has offices in Auckland and Sydney from which they operate across Australasia. They specialise in the marketing, sales, service and support of software and devices used in the radiotherapeutic treatment of cancer. This includes radiotherapy treatment planning systems, medical physics equipment to check and monitor the clinical energies delivered, patient positioning & immobilisation devices, and radiation shielding solutions for bunker construction. They have by far the largest installed base of patient positioning solutions and medical physics devices throughout Australasia, and supply products to every radiotherapy department in Australia and New Zealand. In addition to their radiotherapy products, alphaXRT also manage the design, manufacture and supply of a range of accelerator beam-line equipment to steer, focus, or filter high-energy charged particle beams. This includes Electromagnets, Wein Filters and Electrostatic Analysers that are employed in accelerator installations worldwide.
- Employees
- 11 to 50
Leadership
The top of alphaXRT's org chart, with how many people report into each leader.
Nigel Attwood
Chief Executive Officer
6 reports
Richard Neale
Managing Director
3 reports
Nicki Pettigrew
Chief Operations Officer
Nick Evans
Chief Commercial Officer (CCO)
Jobs at alphaXRT
No open positions right now. Explore more companies on TheJobsMap.
alphaXRT jobs: common questions
- Is alphaXRT hiring right now?
- alphaXRT has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on alphaXRT's careers site.
- Who leads alphaXRT?
- Nigel Attwood, Chief Executive Officer, is at the top of alphaXRT's org chart.
- How do I apply for a job at alphaXRT?
- Pick a role on alphaXRT's TheJobsMap page and select Apply. Every listing links to the original posting on alphaXRT's own careers site, so you apply directly with the employer.